Published on 08th June 2021
Biomerics, a major mid-market medical device contract maker, has announced that it will double its manufacturing footprint in Cartago, Costa Rica's Zeta Free Trade Zone. On February 12, 2021, Biomerics, Zeta, and CINDE staged a joint groundbreaking ceremony.
Extrusion, injection moulding, micro metal processing, and cleanroom assembly are all part of the expansion, which will take place in a new greenfield site close to Biomerics' current operations. The 110,000-square-foot facility will feature engineering laboratories, quality inspection labs, controlled environment manufacturing, office space, class 7 clean rooms, packing, and warehouse facilities, reflecting Biomerics' vertically integrated, full-service company strategy.
Travis Sessions, Biomerics CEO said, "This expansion is in line with our vision to be the leading interventional contract manufacturer, customers have requested that we build a vertically integrated operation in Costa Rica to provide cost-effective high volume manufacturing for the interventional market.”
Biomerics has 175 employees working in its 50,000-square-foot plant, which specialises in extrusion, laser processing, high-volume assembly, and packaging. The growth will support active transfer programmes with strategic clients, and the company expects to increase its Costa Rican workforce in the next three years.
"We are excited for the value that this expansion brings to our existing customer base in Costa Rica and interventional OEM partners around the globe," stated Chris Richardson, Biomerics Director of Sales and Marketing. "The thriving medical device ecosystem in Costa Rica aligns well with Biomerics’ culture and innovative core."